US EditionPublished • loading... • Updated
Cuban Vaccine Will Be Tested to Treat Chikungunya Sequelae
Summary by CiberCuba
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Cuba will begin a clinical study with Jusvinza to treat chikungunya sequelae in Matanzas. The epidemic affects more than 31,000 people, with symptoms such as arthritis and chronic pains.
The municipality of Mayabeque is experiencing one of its worst hygienic crises in decades
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
